6 September – LAWFUEL – The Law News Network – Allen & Overy advised Inyx, Inc., a speciality company with focus on niche drug delivery technologies and products, on its €27.5 million agreement with global biopharmaceutical company, UCB, to acquire Celltech Manufacturing Services Limited (“CMSL”), a UCB subsidiary.
The Allen & Overy team was led by corporate partner Gary McLean and banking partner Francis Bridgeman, assisted by corporate associates Nick Stuart and Sarah Hoskins. Also advising on intellectual property aspects of the transaction was partner Colin Pearson, assisted by associate John Davidson-Kelly.
Commenting Gary McLean said: “We are delighted to have advised Inyx in connection with this strategic acquisition, having previously advised them principally in relation to financing matters. The acquisition will greatly enhance Inyx’s operations and capabilities in Europe and complement their recently established operating base in the Americas. We very much look forward to continuing to work with them.”
Financing for the transaction was provided by Westernbank Puerto Rico who had worked with Inyx on their recent acquisition in Puerto Rico.
Commenting Francis Bridgeman said: “This transaction is another major step in the growth of Inyx and we are pleased to have been part of this. It also represented the first foray of the group’s financiers into the European market and we were delighted to be able to bring to bear Allen & Overy’s breadth of experience to work with our clients to deliver a successful outcome all round.”